FDA Enforcement Class II Completed

Flo-Thru Intraluminal Shunt. Used in coronary artery or peripheral vascular procedures. Used to shunt blood at the anastomosis to provide a temporary blood-free operative field for suturing while allowing blood to flow distal to the anastomosis.

Recall: Z-1019-2022 · Reported May 11, 2022

Enforcement

Recall Number
Z-1019-2022
Event ID
89897
Classification
Class II
Status
Completed
Product Type
Devices
Firm
Baxter Healthcare Corporation
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
May 11, 2022
Initiation Date
April 1, 2022
Classification Date
April 29, 2022
Address
1 Baxter Pkwy, N/A, Deerfield, IL, 60015-4625, United States

Description

Flo-Thru Intraluminal Shunt. Used in coronary artery or peripheral vascular procedures. Used to shunt blood at the anastomosis to provide a temporary blood-free operative field for suturing while allowing blood to flow distal to the anastomosis.

Reason

There is a potential for foreign matter.

Code Info

Product Code: FT12150; Lot: SP21J21-1584173

Distribution

Distribution in the United States including AL, CA, KY, NY, OR, PA, and TX OUS distribution to Japan, Italy, Netherlands, Switzerland, and United Kingdom

Quantity

300 devices